BCL2 and cancer: In this study, we investigate the anti-cancer effects of luteolin on EJ138 BC malignant cells by examining its impact on autophagic, apoptotic, and metastatic gene modulation, specifically targeting ATG12, ULK1, P53, BCL2, MMP2, and MMP9.